Speaker Line Up

Sascha Abramson
PhD

Carisma Therapeutics
United States

Michael Aigner
PhD

University Hospital of Erlangen
Germany

Julie Allickson
PhD

Mayo Clinic
United States

James Ankrum 
PhD

University of Iowa
United States

Jacqueline Barry
PhD

Cell and Gene Therapy Catapult
United Kingdom

Andrew Bellinger
MD, PhD

Verve Therapeutics
United States

Alice Bertaina
MD, PhD

Stanford School of Medicine
United States

Sarindr "Ik" Bhumiratna
PhD

EpiBone
United States

Jaap Jan Boelens
MD, PhD

Memorial Sloan Kettering Cancer Center
United States

Wilson W. Bryan
MD

Greenleaf Health
United States

Edit Buzás
MD, PhD

Semmelweis University & ISEV President
Hungary

Houjian Cai
PhD

University of Georgia
United States

Amander Clark
PhD

President, ISSCR
United States

Corey Cutler
MD, MPH, FRCPC

President, ASTCT
United States

Francesco Dazzi
MD, PhD

AstraZeneca
United Kingdom

Olivier G. de Jong
PhD

Utrecht University
Netherlands

Julie Douville
PhD

n-Lorem Foundation
Canada

Karen English
PhD

Maynooth University
Ireland

Jacques Galipeau
MD

President, ISCT
 University of Wisconsin–Madison
United States

Bernd Giebel
PhD

 University of Duisburg-Essen
Germany

Tracy Heng
PhD

Monash University
Australia

Adrienne Farid
PhD

Century Therapeutics, Inc.
United States

Mark Flower
BSc

Cryoport
United States

Yong Song Gho
Pohang University of Science and Technology
South Korea

Mo Heidaran
PhD

GC Therapeutics
United States

William Hobbs
MD, PhD

Vertex Pharmaceuticals
United States

Sven Kili
MBChB, MRCS (Eng)

Sven Kili Consulting
United Kingdom

Donald B. Kohn
MD

University of California, Los Angeles
United States

Uma Lakshmipathy
PhD

Thermo Fisher
United States

David Lebwohl
MD

Intellia Therapeutics
United States

Bruce Levine
PhD

University of Pennsylvania
United States

Megan K. Levings
PhD

University of British Columbia
Canada

Sai Kiang Lim
PhD

A*Star Institute of Molecular Biology
Singapore

Aby J. Mathew
PhD

ISCT 2024 Co-Chair
Biolife Solutions, Inc.
United States

Sara McCoy
MD, PhD

University of Wisconsin
United States

Remo Moomiaie-Qajar
MD

Cytonus Therapeutics
United States

Timothy Moore
MEng

Allogene Therapeutics
United States

Lise Munsie
PhD

CCRM
Canada

Gi-Hoon Nam
MD, PhD

SHIFTBIO Inc.
South Korea

Susan B. Nichols
BSc

Propel Bio, LLC
United States

Kemi Olugemo
MD, FAAN

Ultragenynx
United States

Madhusudan V. Peshwa
PhD

Tessera Therapeutics
United States

Martine Rothblatt
JD, PhD, MBA

United Therapeutics
United States

Jon Rowley
PhD

RoosterBio
United States

Nooshafarin Sanaie
PhD

Poseida Therapeutics, Inc.
United States

Naohiro Seo
PhD

The University of Tokyo
Japan

Patrick Rivers
BS, MBA

Aquilo Capital Management
United States

Nika Shakiba
PhD

University of British Columbia
Canada

Shigeto Shimmura
MD, PhD

Fujita Medical Innovation Center
Japan

Anna Sureda
MD, PhD

President, EBMT
Spain

Laura Sepp-Lorenzino
PhD

Intellia Therapeutics
United States

Anthony Ting
PhD

Kiji Therapeutics
United States

Carolina Tropini
PhD, PLEng

University of British Columbia
Canada

Fyodor Urnov
PhD

University of California, Berkeley
United States

Bob Valamehr
PhD

Fate Therapeutics
United States

Sowmya Viswanathan
PhD

ISCT 2024 Co-Chair
University Health Network
Canada

Christopher Wegener
MS, BME

Fresenius Kabi
United States

Daniel J. Weiss
MD, PhD

ISCT 2024 Co-Chair
 University of Vermont
United States

Martin Westberg
MSc

Cytiva
United States

Emily Whitehead
Emily Whitehead Foundation
United States

Tom Whitehead
Emily Whitehead Foundation
United States

Marcus Yountz
MD, FAAN

BlueRock Therapeutics
United States

Xiaokui Zhang
PhD

Aspen Neuroscience
United States